Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia

This study has been completed.
Celgene Corporation
Information provided by:
National Institutes of Health Clinical Center (CC) Identifier:
First received: June 22, 2012
Last updated: October 28, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2015
  Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)